vs

Side-by-side financial comparison of ONESPAWORLD HOLDINGS Ltd (OSW) and Oncology Institute, Inc. (TOI). Click either name above to swap in a different company.

ONESPAWORLD HOLDINGS Ltd is the larger business by last-quarter revenue ($242.1M vs $142.0M, roughly 1.7× Oncology Institute, Inc.). ONESPAWORLD HOLDINGS Ltd runs the higher net margin — 5.0% vs -5.3%, a 10.3% gap on every dollar of revenue. On growth, Oncology Institute, Inc. posted the faster year-over-year revenue change (41.6% vs 11.5%). ONESPAWORLD HOLDINGS Ltd produced more free cash flow last quarter ($14.9M vs $2.2M). Over the past eight quarters, Oncology Institute, Inc.'s revenue compounded faster (22.5% CAGR vs 7.1%).

Oncology Institute, Inc. is a specialized healthcare enterprise focused on delivering patient-centric, evidence-based oncology care services, including advanced treatment regimens, clinical trial access, and supportive care programs. It primarily operates across the United States, serving patients with diverse cancer diagnoses and partnering with care teams to improve treatment outcomes.

OSW vs TOI — Head-to-Head

Bigger by revenue
OSW
OSW
1.7× larger
OSW
$242.1M
$142.0M
TOI
Growing faster (revenue YoY)
TOI
TOI
+30.1% gap
TOI
41.6%
11.5%
OSW
Higher net margin
OSW
OSW
10.3% more per $
OSW
5.0%
-5.3%
TOI
More free cash flow
OSW
OSW
$12.7M more FCF
OSW
$14.9M
$2.2M
TOI
Faster 2-yr revenue CAGR
TOI
TOI
Annualised
TOI
22.5%
7.1%
OSW

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
OSW
OSW
TOI
TOI
Revenue
$242.1M
$142.0M
Net Profit
$12.1M
$-7.5M
Gross Margin
Operating Margin
6.8%
-4.9%
Net Margin
5.0%
-5.3%
Revenue YoY
11.5%
41.6%
Net Profit YoY
-16.2%
43.0%
EPS (diluted)
$0.12
$-0.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
OSW
OSW
TOI
TOI
Q4 25
$242.1M
$142.0M
Q3 25
$258.5M
$136.6M
Q2 25
$240.7M
$119.8M
Q1 25
$219.6M
$104.4M
Q4 24
$217.2M
$100.3M
Q3 24
$241.7M
$99.9M
Q2 24
$224.9M
$98.6M
Q1 24
$211.2M
$94.7M
Net Profit
OSW
OSW
TOI
TOI
Q4 25
$12.1M
$-7.5M
Q3 25
$24.3M
$-16.5M
Q2 25
$19.9M
$-17.0M
Q1 25
$15.3M
$-19.6M
Q4 24
$14.4M
$-13.2M
Q3 24
$21.6M
$-16.1M
Q2 24
$15.8M
$-15.5M
Q1 24
$21.2M
$-19.9M
Operating Margin
OSW
OSW
TOI
TOI
Q4 25
6.8%
-4.9%
Q3 25
10.2%
-5.9%
Q2 25
9.2%
-9.4%
Q1 25
7.7%
-9.5%
Q4 24
7.9%
-11.9%
Q3 24
10.3%
-13.9%
Q2 24
8.4%
-16.6%
Q1 24
8.0%
-19.0%
Net Margin
OSW
OSW
TOI
TOI
Q4 25
5.0%
-5.3%
Q3 25
9.4%
-12.1%
Q2 25
8.3%
-14.2%
Q1 25
7.0%
-18.8%
Q4 24
6.6%
-13.1%
Q3 24
8.9%
-16.1%
Q2 24
7.0%
-15.7%
Q1 24
10.0%
-21.0%
EPS (diluted)
OSW
OSW
TOI
TOI
Q4 25
$0.12
$-0.04
Q3 25
$0.23
$-0.14
Q2 25
$0.19
$-0.15
Q1 25
$0.15
$-0.21
Q4 24
$0.13
$-0.14
Q3 24
$0.20
$-0.18
Q2 24
$0.15
$-0.17
Q1 24
$0.21
$-0.22

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
OSW
OSW
TOI
TOI
Cash + ST InvestmentsLiquidity on hand
$16.3M
Total DebtLower is stronger
$84.0M
Stockholders' EquityBook value
$542.6M
$-15.7M
Total Assets
$707.1M
$164.7M
Debt / EquityLower = less leverage
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
OSW
OSW
TOI
TOI
Q4 25
$16.3M
Q3 25
$29.6M
Q2 25
$35.0M
Q1 25
$22.6M
Q4 24
$57.4M
Q3 24
$48.8M
Q2 24
$62.5M
$9.9M
Q1 24
$65.4M
$29.8M
Total Debt
OSW
OSW
TOI
TOI
Q4 25
$84.0M
Q3 25
$85.2M
Q2 25
$96.2M
Q1 25
$97.4M
Q4 24
$98.6M
Q3 24
$98.7M
Q2 24
$123.8M
Q1 24
$138.6M
Stockholders' Equity
OSW
OSW
TOI
TOI
Q4 25
$542.6M
$-15.7M
Q3 25
$552.8M
$-12.3M
Q2 25
$548.3M
$-9.0M
Q1 25
$530.6M
$5.1M
Q4 24
$554.5M
$3.6M
Q3 24
$540.1M
$15.5M
Q2 24
$532.7M
$29.2M
Q1 24
$515.5M
$41.3M
Total Assets
OSW
OSW
TOI
TOI
Q4 25
$707.1M
$164.7M
Q3 25
$732.6M
$163.6M
Q2 25
$731.8M
$159.8M
Q1 25
$708.7M
$164.0M
Q4 24
$746.4M
$172.7M
Q3 24
$734.0M
$179.2M
Q2 24
$756.8M
$179.6M
Q1 24
$763.6M
$204.5M
Debt / Equity
OSW
OSW
TOI
TOI
Q4 25
0.15×
Q3 25
0.15×
Q2 25
0.18×
Q1 25
0.18×
Q4 24
0.18×
Q3 24
0.18×
Q2 24
0.23×
Q1 24
0.27×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
OSW
OSW
TOI
TOI
Operating Cash FlowLast quarter
$20.0M
$3.2M
Free Cash FlowOCF − Capex
$14.9M
$2.2M
FCF MarginFCF / Revenue
6.2%
1.5%
Capex IntensityCapex / Revenue
2.1%
0.7%
Cash ConversionOCF / Net Profit
1.65×
TTM Free Cash FlowTrailing 4 quarters
$68.4M
$-27.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
OSW
OSW
TOI
TOI
Q4 25
$20.0M
$3.2M
Q3 25
$33.2M
$-12.6M
Q2 25
$20.3M
$-10.2M
Q1 25
$10.1M
$-5.0M
Q4 24
$16.6M
$4.2M
Q3 24
$28.6M
$819.0K
Q2 24
$18.7M
$-15.7M
Q1 24
$15.0M
$-15.9M
Free Cash Flow
OSW
OSW
TOI
TOI
Q4 25
$14.9M
$2.2M
Q3 25
$27.6M
$-13.2M
Q2 25
$17.6M
$-11.4M
Q1 25
$8.4M
$-5.3M
Q4 24
$13.2M
$2.4M
Q3 24
$27.5M
$417.0K
Q2 24
$17.6M
$-17.5M
Q1 24
$13.7M
$-16.5M
FCF Margin
OSW
OSW
TOI
TOI
Q4 25
6.2%
1.5%
Q3 25
10.7%
-9.7%
Q2 25
7.3%
-9.5%
Q1 25
3.8%
-5.1%
Q4 24
6.1%
2.4%
Q3 24
11.4%
0.4%
Q2 24
7.8%
-17.7%
Q1 24
6.5%
-17.4%
Capex Intensity
OSW
OSW
TOI
TOI
Q4 25
2.1%
0.7%
Q3 25
2.2%
0.4%
Q2 25
1.1%
1.0%
Q1 25
0.8%
0.3%
Q4 24
1.5%
1.8%
Q3 24
0.5%
0.4%
Q2 24
0.5%
1.9%
Q1 24
0.6%
0.6%
Cash Conversion
OSW
OSW
TOI
TOI
Q4 25
1.65×
Q3 25
1.36×
Q2 25
1.02×
Q1 25
0.66×
Q4 24
1.15×
Q3 24
1.33×
Q2 24
1.19×
Q1 24
0.71×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

OSW
OSW

Services$197.3M82%
Products$44.8M18%

TOI
TOI

Other$82.1M58%
Fee For Service$36.3M26%
Capitated Revenue$23.6M17%

Related Comparisons